SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 120 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $395,000 | +40.6% | 22,000 | -7.6% | 0.00% | +100.0% |
Q3 2017 | $281,000 | -43.0% | 23,800 | -34.6% | 0.00% | -66.7% |
Q4 2016 | $493,000 | +2494.7% | 36,400 | +2041.2% | 0.00% | – |
Q2 2016 | $19,000 | – | 1,700 | +5971.4% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 28 | -98.0% | 0.00% | – |
Q3 2015 | $28,000 | – | 1,423 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |